Pregnancy and IBD: Biologic risks similar to general population

Adverse pregnancy outcomes among women with inflammatory bowel disease on biologic therapy were comparable to that of the general population, according to study results.Ole Haagen Nielsen, MD, of the department of gastroenterology at Herlev Hospital in Denmark, and colleagues wrote that most IBD medications are safe to continue during pregnancy, but medication compliance is not universal.“Patients often misperceive the risks and discontinue treatment before or during pregnancy, as one study revealed that only 60% to 75% of pregnant women complied with their recommended treatment plan,”Read More

Share on facebook
Share on twitter
Share on linkedin